Use of the triaxial microcatheter method in super-selective transcatheter arterial chemoembolisation for hepatocellular carcinoma.
OBJECTIVE
Transcatheter arterial chemoembolisation (TACE) has been widely used for inoperable hepatocellular carcinoma (HCC). Super-selective TACE is preferable to non-selective therapy, because it maximises the impact of treatment on the tumour while minimising damage to tumour-free liver parenchyma. It is therefore important to advance the catheter tip as close as possible in the feeding artery. There is now a new microcatheter with a 1.9-Fr tip with no taper, which can be inserted into a 2.7-Fr microcatheter. In this study we describe the new technique of using the two microcatheters called the triaxial microcatheter method.


METHODS
We evaluated 30 TACE procedures to investigate whether or not the catheter tip could be advanced closer to HCC with the triaxial microcatheter method than with previous TACE using a conventional microcatheter.


RESULTS
With conventional microcatheters, the level of embolisation was a lobar artery in 4 cases, segmental in 8 cases, subsegmental in 15 cases and sub-subsegmental in only 1 case. TACE could not be performed in two cases. When using the triaxial microcatheter method the level of embolisation was subsegmental in 8 cases, including 2 in which the level was the same as that with a conventional microcatheter, sub-subsegmental in 13 cases and more distal in 7 cases. In the two cases in which TACE could not be performed with the conventional microcatheter, it could be performed sufficiently using the new method. As a whole, in 28 of the 30 procedures (93%) we could successfully advance a catheter tip closer than with the previous TACE.


CONCLUSIONS
The triaxial microcatheter method appears to be useful.
Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Japan. m_shimohira@yahoo.co.jp
M
M
Shimohira
H
H
Ogino
T
T
Kawai
A
A
Kushita
M
M
Watanabe
T
T
Kawaguchi
K
K
Kurono
Y
Y
Shibamoto
D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000098:blood supply / Q000628:therapy*; D002404:Catheterization; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000098:blood supply / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
CA Cancer J Clin. 1999 Jan-Feb;49(1):8-31, 1
10200775
Radiology. 1993 Jul;188(1):79-83
8390073
J Vasc Interv Radiol. 1993 Jul-Aug;4(4):543-9
8394758
N Engl J Med. 1999 Mar 11;340(10):745-50
10072408
Cancer. 1991 Jan 15;67(2):385-91
1845943
Gastroenterology. 2006 Aug;131(2):461-9
16890600
Ann Surg. 1996 Jul;224(1):4-9
8678616
Cardiovasc Intervent Radiol. 1990 Jun-Jul;13(3):140-5
2171772
J Vasc Interv Radiol. 2007 Dec;18(12):1517-26; quiz 1527
18057286
Cancer. 1994 Jul 1;74(1):16-24
7516263